ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS MCDA AS A POSSIBLE NEW PARADIGM IN HEALTH CARE DECISION MAKING

Published May 24, 2016
Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon in Washington, DC, USA. The Issue Panel moderator was James Dolan, MD, Professor, University of Rochester, Rochester, NY, USA. Panelists included:
  • Kevin Marsh, PhD, Executive Director, Evidera, London, UK
  • Mireille M. Goetghebeur, PhD, MEng, Global Scientist, LASER Analytica and School of Public Health, University of Montreal, Montreal, QC, Canada
  • Mabel Moreno Viscaya, PhD, Senior Economist, Instituto de Evaluación Tecnológica en Salud (IETS), Bogata, Colombia
Multiple criteria decision analysis (MCDA), an application of decision analytics that can help improve the quality of complicated decisions, is gaining significant interest in health care. MCDA application in health care decision making can also be subject to controversy. For example, while many MCDA methods are available, little guidance currently exists for how to choose the right technique for a particular problem. The ISPOR Multi-Criteria Decision Analysis in Health Care Decision Making Emerging Good Practices Task Force was established in 2014 to help fill this knowledge gap. The panel used content from a two-day workshop that convened MCDA experts from around the world to illustrate and spark discussion of the controversies and complexities of health care decisions. The panelists encouraged attendees to apply MCDA in health economics and outcomes research to provide a way to change the current paradigm in health care decision making. Additional information and resources on MCDA can be found on the ISPOR website, including: Presentations and slide decks from the ISPOR 21st Annual International meeting can be found here. Interested parties can follow news and developments from the meeting on social media using the hashtag #ISPORDC.

###

Related Stories

ISPOR Announces New Strategic Plan 2030

Jul 29, 2024

ISPOR announced its new Strategic Plan 2030 that presents a bold new vision for the Society and the field of health economics and outcomes research (HEOR).

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×